VanEck Associates
CORZ

VanEck Associates’s Core Scientific, Inc. Common Stock CORZ Stock Holding History

VanEck Associates’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,297,136
Closed -$1.69M – 1471
2022
Q3 		$1.69M Buy
1,297,136
+209,719
+19% +$446K 0.01% 685
2022
Q2 		$1.62M Buy
1,087,417
+513,770
+90% +$2.36M ﹤0.01% 699
2022
Q1 		$4.72M Buy
+573,647
New +$5.07M 0.01% 516

Other funds holding CORZ

PFO
Pathstone Family Office Englewood, New Jersey $13.1B AUM 21.02% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Comerica Bank
Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PWM
Perigon Wealth Management San Francisco, California $5.51B AUM 24.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
STA
Summit Trail Advisors New York $6.98B AUM 19.51% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
CCM
Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

VanEck Associates's CORZ Position: Q4 2022 in Review

VanEck Associates sold out of Core Scientific, Inc. Common Stock (CORZ) in Q4 2022, closing a stake of 1,297,136 shares — an estimated $1.69M sold.

VanEck Associates first reported a position in CORZ in Q1 2022 and held it in 3 quarters. The position peaked at $4.72M in Q1 2022. 89 funds tracked by Wall St. Rank hold CORZ as of Q4 2022.

  • VanEck Associates reported no remaining Core Scientific, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • VanEck Associates sold 1,297,136 Core Scientific, Inc. Common Stock shares in Q4 2022, an estimated $1.69M.
  • VanEck Associates first reported a position in Core Scientific, Inc. Common Stock in Q1 2022 and held it in 3 quarters.
  • VanEck Associates's Core Scientific, Inc. Common Stock position peaked at $4.72M in Q1 2022.
  • 89 funds tracked by Wall St. Rank held Core Scientific, Inc. Common Stock as of Q4 2022.

Based on VanEck Associates's 13F filing for Q4 2022, filed 8 Feb 2023.